Outcome of Patients Treated With ECLS

Outcome of Patients Treated With Extracorporeal Life Support

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04405817

Enrollment

300

Registered

2020-05-28

Start date

2012-01-01

Completion date

2025-12-31

Last updated

2020-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome, Acute Respiratory Failure, Cardiac Arrest, Cardiogenic Shock, Heart Failure

Brief summary

Extracorporeal life support (ECLS), also called extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective circulatory and (or) respiratory failure, with a growing number of critically ill patients benefit from it. The aim of this study is to investigate the outcome of patients treated With ECMO, and to evaluate the short-term and long-term outcomes of patients with ECLS.

Interventions

DEVICEECMO

ECMO for circulatory and/or respiratory support

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Years to 100 Years

Inclusion criteria

* Patients receiving ECMO for circulatory and/or respiratory support

Exclusion criteria

* Refusal of consent

Design outcomes

Primary

Measure	Time frame
Composite of death from any cause, resuscitated circulatory arrest, and implantation of another mechanical circulatory support device	30 days after ECMO implantation

Secondary

Measure	Time frame
All-cause mortality	30 days after ECMO implantation

Countries

China

Contacts

Primary ContactHong Liu, MD

DR.HONGLIU@FOXMAIL.COM18801281613

Backup ContactYong-feng Shao, MD

yfshaojph@sina.com02568303100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026